Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 31, 2021Omeprazole Delayed Release CapsulesFailed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturerGolden State Medical Supply Inc. · D-0312-2021Class ITerminatedMar 31, 2021Adam's Secret Extra Strength 3000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.Adams.Secret.co · D-0311-2021Class ITerminatedMar 31, 2021Adam's Secret Extra Strength 1500Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.Adams.Secret.co · D-0310-2021Class IIITerminatedMar 24, 2021Romidepsin InjectonFailed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.Teva Pharmaceuticals USA · D-0309-2021Class IITerminatedMar 24, 2021Omeprazole Delayed-Release CapsulesFailed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.Breckenridge Pharmaceutical, Inc · D-0308-2021Class IIITerminatedMar 24, 2021Epinephrine/Lidocaine HClLabeling: Incorrect or Missing Lot and/or Exp DateEdge Pharma, LLC · D-0307-2021Class IIITerminatedMar 24, 2021Methacholine Challenge 5-Syringe Test KitsTemperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditionsEdge Pharma, LLC · D-0306-2021Class IITerminatedMar 24, 2021Phenylephrine HCl InjectionLack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.Sagent Pharmaceuticals Inc · D-0305-2021Class IIOngoingMar 24, 2021Spironolactone TabletsLabeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals · D-0304-2021Class IOngoingMar 24, 2021Spironolactone TabletsLabeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals · D-0303-2021Class IITerminatedMar 24, 2021Gabapentin Oral SolutionFailed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testingAkorn, Inc. · D-0301-2021Class IITerminatedMar 24, 2021Nortriptyline HCL capsulescGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that...Direct Rx · D-0300-2021Class IIITerminatedMar 17, 2021Menopur 75 IUFailed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USPFerring Pharmaceuticals Inc · D-0299-2021Class IIITerminatedMar 10, 2021Methylprednisolone Tablets USPLabeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.Jubilant Cadista Pharmaceuticals, Inc. · D-0298-2021Class IITerminatedMar 10, 2021Metoclopramide Injection USPChemical contamination; Unknown brown residue adhering to the inside of one vial.Teva Pharmaceuticals USA · D-0297-2021Class IITerminatedMar 10, 2021DaytranaDefective Delivery System: Out of specification for mechanical peel.Noven Pharmaceuticals Inc · D-0296-2021Class IITerminatedMar 10, 2021DaytranaDefective Delivery System: Out of specification for mechanical peel.Noven Pharmaceuticals Inc · D-0295-2021Class IITerminatedMar 10, 2021DaytranaDefective Delivery System: Out of specification for mechanical peel.Noven Pharmaceuticals Inc · D-0294-2021Class IITerminatedMar 10, 2021DaytranaDefective Delivery System: Out of specification for mechanical peel.Noven Pharmaceuticals Inc · D-0293-2021Class IITerminatedMar 10, 2021Progesterone CapsulesFailed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.Dr. Reddy's Laboratories, Inc. · D-0292-2021Class IIITerminatedMar 10, 2021Atorvastatin Calcium TabletsFailed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impuritiesDr. Reddy's Laboratories, Inc. · D-0291-2021Class IITerminatedMar 10, 2021Famotidine Tablets USP 40mgPresence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.Aurobindo Pharma USA Inc. · D-0290-2021Class IIITerminatedMar 10, 2021Cequa (cyclosporine ophthalmic solution) 0.09%SubpotentSun Pharmaceutical Industries Inc · D-0289-2021Class IITerminatedMar 3, 2021Fludeoxyglucose F 18 InjectionLack of Assurance of SterilityThe General Hospital Corporation · D-0288-2021Class IITerminatedMar 3, 2021Imatinib Mesylate Tablets 100mgFailed Dissolution SpecificationsDr. Reddy's Laboratories, Inc. · D-0287-2021Class ITerminatedMar 3, 2021Cisatracurium Besylate InjectionLabeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but...Meitheal Pharmaceuticals Inc · D-0286-2021Class IITerminatedMar 3, 2021Leucovorin Calcium for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0285-2021Class IITerminatedMar 3, 2021MethyIPREDNISolone Acetate Injectable Suspension USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0284-2021Class IITerminatedMar 3, 2021MethyIPREDNISolone Acetate Injectable Suspension USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0283-2021Class IITerminatedMar 3, 2021MethyIPREDNISolone Acetate Injectable Suspension USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0282-2021Class IITerminatedMar 3, 2021MethyIPREDNISolone Acetate Injectable Suspension USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0281-2021Class IITerminatedMar 3, 2021Epoprostenol Sodium for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0280-2021Class IITerminatedMar 3, 2021Vecuronium Bromide for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0279-2021Class IITerminatedMar 3, 2021ToposarLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0278-2021Class IITerminatedMar 3, 2021Metoclopramide Injection USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0277-2021Class IITerminatedMar 3, 2021Leucovorin Calcium for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0276-2021Class IITerminatedMar 3, 2021MethyIPREDNISolone Acetate Injectable Suspension USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0275-2021Class IITerminatedMar 3, 2021Epoprostenol Sodium for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0274-2021Class IITerminatedMar 3, 2021Sterile Diluent for Epoprostenol Sodium for InjectionLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0273-2021Class IITerminatedMar 3, 2021Desmopressin Acetate Injection USPLack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance...Teva Pharmaceuticals USA · D-0272-2021